MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
19.46
+0.13
+0.67%
Opening 11:14 09/24 EDT
OPEN
19.29
PREV CLOSE
19.33
HIGH
19.62
LOW
19.19
VOLUME
240.83K
TURNOVER
--
52 WEEK HIGH
21.18
52 WEEK LOW
9.49
MARKET CAP
6.21B
P/E (TTM)
40.61
1D
5D
1M
3M
1Y
5Y
1D
Oppenheimer Initiates Coverage of Amneal Pharmaceuticals at Outperform
NASDAQ · 19h ago
Amneal Pharmaceuticals Price Target Announced at $27.00/Share by Oppenheimer
Dow Jones · 1d ago
Oppenheimer Initiates Coverage On Amneal Pharmaceuticals with Outperform Rating, Announces Price Target of $27
Benzinga · 1d ago
Amneal: Even My Bull Case Barely Justifies $20/Share
Seeking Alpha · 2d ago
Biotech Stocks At 52-Week Highs - AMRX, BLSM, NEOG. NEO
NASDAQ · 2d ago
Amneal Pharmaceuticals Up Over 11%, on Track for Highest Close Since October 2018 -- Data Talk
Dow Jones · 3d ago
Why Is Amneal (AMRX) Stock Rocketing Higher Today
Barchart · 3d ago
Chris Schott Initiates Buy on Amneal, Citing Lanreotide Launch and Biosimilar-Driven Growth Outlook Through 2027
TipRanks · 3d ago
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.